| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e0a3e9578100cf105d929d0027b7ced |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-095 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C25B3-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C25B3-23 |
| filingDate |
1992-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dda852bfcf331458ff507557f32a43f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26a702eaaf6e13e82155f42fefb927f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f271d32618e6665cf6df4b9f11cba9d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_543b019827d670a882c1352897a3531d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80d6100920d069f548ac4db5544a2261
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_220a202dd4ef4804ea56a5126d5bc954
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b590ff1436a17391d7f1da35560d2b6 |
| publicationDate |
1993-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0529081-A1 |
| titleOfInvention |
HALOGENATED $g(b)-LACTAM COMPOUND AND PRODUCTION OF 3-HYDROXYCEPHEM DERIVATIVE THEREFROM |
| abstract |
A halogenated β-lactam compound represented by general formula (III), wherein Ar represents optionally substituted aryl; R¹ represents optionally protected amino; R² represents hydrogen or a carboxyl blocking group; R³ represents hydrogen or a hydroxyl blocking group; and X represents halogen. A process for producing a 3-hydroxycephem derivative is represented by general formula (I) in an industrially advantageous manner by reducing the compound (III) either with a metallic reducing agent or electrolytically. In formula (I), R¹, R² and R³ are as defined above. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6197185-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1225176-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5905147-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0759428-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0759428-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6043356-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1225176-A2 |
| priorityDate |
1991-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |